This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rogatsky, I.
Right arrow Articles by Garabedian, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rogatsky, I.
Right arrow Articles by Garabedian, M. J.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, July 1999, p. 5036-5049, Vol. 19, No. 7
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Distinct Glucocorticoid Receptor Transcriptional Regulatory Surfaces Mediate the Cytotoxic and Cytostatic Effects of Glucocorticoids

Inez Rogatsky,1 Adam B. Hittelman,1 David Pearce,2 and Michael J. Garabedian1,*

Department of Microbiology and the Kaplan Comprehensive Cancer Center, New York University School of Medicine, New York, New York 10016,1 and Departments of Medicine and Cellular and Molecular Pharmacology, University of California---San Francisco, San Francisco, California 941432

Received 24 November 1998/Returned for modification 12 January 1999/Accepted 1 April 1999

Glucocorticoids act through the glucocorticoid receptor (GR), which can function as a transcriptional activator or repressor, to elicit cytostatic and cytotoxic effects in a variety of cells. The molecular mechanisms regulating these events and the target genes affected by the activated receptor remain largely undefined. Using cultured human osteosarcoma cells as a model for the GR antiproliferative effect, we demonstrate that in U20S cells, GR activation leads to irreversible growth inhibition, apoptosis, and repression of Bcl2. This cytotoxic effect is mediated by GR's transcriptional repression function, since transactivation-deficient mutants and ligands still bring about apoptosis and Bcl2 down-regulation. In contrast, the antiproliferative effect of GR in SAOS2 cells is reversible, does not result in apoptosis or repression of Bcl2, and is a function of the receptor's ability to stimulate transcription. Thus, the cytotoxic versus cytostatic outcome of glucocorticoid treatment is cell context dependent. Interestingly, the cytostatic effect of glucocorticoids in SAOS2 cells involves multiple GR activation surfaces. GR mutants and ligands that disrupt individual transcriptional activation functions (activation function 1 [AF-1] and AF-2) or receptor dimerization fail to fully inhibit cellular proliferation and, remarkably, discriminate between the targets of GR's cytostatic action, the cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1. Induction of p21Cip1 is agonist dependent and requires AF-2 but not AF-1 or GR dimerization. In contrast, induction of p27Kip1 is agonist independent, does not require AF-2 or AF-1, but depends on GR dimerization. Our findings indicate that multiple GR transcriptional regulatory mechanisms that employ distinct receptor surfaces are used to evoke either the cytostatic or cytotoxic response to glucocorticoids.

* Corresponding author. Mailing address: Department of Microbiology and the Kaplan Comprehensive Cancer Center, New York University School of Medicine, New York, NY 10016. Phone: (212) 263-7662. Fax: (212) 263-8276. E-mail: garabm01{at}mcrcr.med.nyu.edu.

Molecular and Cellular Biology, July 1999, p. 5036-5049, Vol. 19, No. 7
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Matthews, L., Berry, A., Tersigni, M., D'Acquisto, F., Ianaro, A., Ray, D. (2009). Thiazolidinediones Are Partial Agonists for the Glucocorticoid Receptor. Endocrinology 150: 75-86 [Abstract] [Full Text]  
  • Yang, J.-Q., Rudiger, J. J., Hughes, J. M., Goulet, S., Gencay-Cornelson, M. M., Borger, P., Tamm, M., Roth, M. (2008). Cell Density and Serum Exposure Modify the Function of the Glucocorticoid Receptor C/EBP Complex. Am. J. Respir. Cell Mol. Bio. 38: 414-422 [Abstract] [Full Text]  
  • Lu, N. Z., Collins, J. B., Grissom, S. F., Cidlowski, J. A. (2007). Selective Regulation of Bone Cell Apoptosis by Translational Isoforms of the Glucocorticoid Receptor. Mol. Cell. Biol. 27: 7143-7160 [Abstract] [Full Text]  
  • Almawi, W. Y., Melemedjian, O. K., Jaoude, M. M. A. (2004). On the link between Bcl-2 family proteins and glucocorticoid-induced apoptosis. J. Leukoc. Biol. 76: 7-14 [Abstract] [Full Text]  
  • Wang, Z., Garabedian, M. J. (2003). Modulation of Glucocorticoid Receptor Transcriptional Activation, Phosphorylation, and Growth Inhibition by p27Kip1. J. Biol. Chem. 278: 50897-50901 [Abstract] [Full Text]  
  • Rogatsky, I., Wang, J.-C., Derynck, M. K., Nonaka, D. F., Khodabakhsh, D. B., Haqq, C. M., Darimont, B. D., Garabedian, M. J., Yamamoto, K. R. (2003). Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 100: 13845-13850 [Abstract] [Full Text]  
  • De Bosscher, K., Vanden Berghe, W., Haegeman, G. (2003). The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression. Endocr. Rev. 24: 488-522 [Abstract] [Full Text]  
  • Tse, R., Marroquin, B. A., Dorscheid, D. R., White, S. R. (2003). {beta}-Adrenergic agonists inhibit corticosteroid-induced apoptosis of airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L393-L404 [Abstract] [Full Text]  
  • Kauppi, B., Jakob, C., Farnegardh, M., Yang, J., Ahola, H., Alarcon, M., Calles, K., Engstrom, O., Harlan, J., Muchmore, S., Ramqvist, A.-K., Thorell, S., Ohman, L., Greer, J., Gustafsson, J.-A., Carlstedt-Duke, J., Carlquist, M. (2003). The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding Domain: RU-486 INDUCES A TRANSCONFORMATION THAT LEADS TO ACTIVE ANTAGONISM. J. Biol. Chem. 278: 22748-22754 [Abstract] [Full Text]  
  • Inoue, H., Furukawa, T., Giannakopoulos, S., Zhou, S., King, D. S., Tanese, N. (2002). Largest Subunits of the Human SWI/SNF Chromatin-remodeling Complex Promote Transcriptional Activation by Steroid Hormone Receptors. J. Biol. Chem. 277: 41674-41685 [Abstract] [Full Text]  
  • Greenberg, A. K., Hu, J., Basu, S., Hay, J., Reibman, J., Yie, T.-a., Tchou-Wong, K. M., Rom, W. N., Lee, T. C. (2002). Glucocorticoids Inhibit Lung Cancer Cell Growth through Both the Extracellular Signal-Related Kinase Pathway and Cell Cycle Regulators. Am. J. Respir. Cell Mol. Bio. 27: 320-328 [Abstract] [Full Text]  
  • Kucera, T., Waltner-Law, M., Scott, D. K., Prasad, R., Granner, D. K. (2002). A Point Mutation of the AF2 Transactivation Domain of the Glucocorticoid Receptor Disrupts Its Interaction with Steroid Receptor Coactivator 1. J. Biol. Chem. 277: 26098-26102 [Abstract] [Full Text]  
  • CROCHEMORE, C., MICHAELIDIS, T. M., FISCHER, D., LOEFFLER, J.-P., ALMEIDA, O. F. X. (2002). Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation. FASEB J. 16: 761-770 [Abstract] [Full Text]  
  • Greenstein, S., Ghias, K., Krett, N. L., Rosen, S. T. (2002). Mechanisms of Glucocorticoid-mediated Apoptosis in Hematological Malignancies. Clin. Cancer Res. 8: 1681-1694 [Abstract] [Full Text]  
  • Smith, E., Coetzee, G. A., Frenkel, B. (2002). Glucocorticoids Inhibit Cell Cycle Progression in Differentiating Osteoblasts via Glycogen Synthase Kinase-3beta. J. Biol. Chem. 277: 18191-18197 [Abstract] [Full Text]  
  • Zhang, H. H., Kumar, S., Barnett, A. H., Eggo, M. C. (2001). Dexamethasone Inhibits Tumor Necrosis Factor-{{alpha}}-Induced Apoptosis and Interleukin-1{beta} Release in Human Subcutaneous Adipocytes and Preadipocytes. J. Clin. Endocrinol. Metab. 86: 2817-2825 [Abstract] [Full Text]  
  • Tao, Y., Williams-Skipp, C., Scheinman, R. I. (2001). Mapping of Glucocorticoid Receptor DNA Binding Domain Surfaces Contributing to Transrepression of NF-kappa B and Induction of Apoptosis. J. Biol. Chem. 276: 2329-2332 [Abstract] [Full Text]  
  • Smith, E., Redman, R. A., Logg, C. R., Coetzee, G. A., Kasahara, N., Frenkel, B. (2000). Glucocorticoids Inhibit Developmental Stage-specific Osteoblast Cell Cycle. DISSOCIATION OF CYCLIN A-CYCLIN-DEPENDENT KINASE 2 FROM E2F4-p130 COMPLEXES. J. Biol. Chem. 275: 19992-20001 [Abstract] [Full Text]  
  • Singh, P., Chan, S. W., Hong, W. (2001). Retinoblastoma Protein Is Functionally Distinct from Its Homologues in Affecting Glucocorticoid Receptor-mediated Transcription and Apoptosis. J. Biol. Chem. 276: 13762-13770 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»